LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2016.00190
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Neutrophil:Lymphocyte Ratios Have Prognostic Value in Triple-Negative Breast Cancer

Journal of Nihon University Medical Association
2017English

Prognostic Significance of Progesterone Receptor Expression in Estrogen-Receptor Positive, HER2-Negative, Node-Negative Invasive Breast Cancer With a Low Ki-67 Labeling Index

Clinical Breast Cancer
Cancer ResearchOncology
2017English

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

Statins May Reduce Breast Cancer Risk, Particularly Hormone Receptor-Negative Disease

Current Breast Cancer Reports
Oncology
2009English

Prognostic Value of Kallikrein-Related Peptidase 12 (KLK12) mRNA Expression in Triple-Negative Breast Cancer Patients

Molecular Medicine
Molecular MedicineGeneticsMolecular Biology
2020English

Prognostic Value of IRF-2 Expression in Colorectal Cancer

Oncotarget
Oncology
2017English

PTEN Expression in Benign Human Endometrial Tissue and Cancer in Relation to Endometrial Cancer Risk Factors

Cancer Causes and Control
Cancer ResearchOncology
2015English

P53 Mutations Have No Additional Prognostic Value Over Stage in Bladder Cancer

British Journal of Cancer
Cancer ResearchOncology
1994English

Prognostic Value of microRNA-126 and CRK Expression in Gastric Cancer

OncoTargets and Therapy
OncologyPharmacology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy